Travere Therapeutics and partner CSL Vifor could be weeks away from EU approval of sparsentan for IgA nephropathy, after getting a positive opinion on the drug from the EMA’s human medicines ...
Copyright © 2024 MarketWatch, Inc. All rights reserved.
Copyright © 2024 MarketWatch, Inc. All rights reserved.
The other two are CSL Behring, focused on biotherapies and rare diseases, and CSL Vifor, focused on iron deficiency and nephrology. CSL Ltd. has over 32,000 employees working in more than 40 countries ...
Research, development, manufacture, marketing and distribution of biopharmaceutical products and vaccines.
New York Sirens Professional Womens Hockey League November 7, 2024 New York Sirens Professional Womens Hockey League November 7, 2024 Montreal Victoire Professional Womens Hockey League November 7, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback